Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
European Heart Journal
|
March 27, 2018
New prospects for PCSK9 inhibition?
Ulf Landmesser, M John Chapman, Jane K Stock, et al.
International Journal of Behavioral Medicine
|
October 25, 2012
European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Joep Perk, Guy De Backer, Helmut Gohlke, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 30, 2022
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary
Adam Timmis, Panos Vardas, Nick Townsend, et al.
European Heart Journal
|
October 19, 2017
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
Ulf Landmesser, M John Chapman, Jane K Stock, et al.
Atherosclerosis
|
June 16, 2012
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
Joep Perk, Guy De Backer, Helmut Gohlke, et al.
Nature Plants
|
December 17, 2020
Author Correction: Selection of a subspecies-specific diterpene gene cluster implicated in rice disease resistance
Chuansong Zhan, Long Lei, Zixin Liu, et al.
Nature Plants
|
December 10, 2020
Selection of a subspecies-specific diterpene gene cluster implicated in rice disease resistance
Chuansong Zhan, Long Lei, Zixin Liu, et al.
European Heart Journal
|
August 30, 2007
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 2, 2017
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
Ian Graham, Chuck Shear, Pieter De Graeff, et al.
European Heart Journal
|
February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
Steven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
European Heart Journal
|
March 27, 2018
New prospects for PCSK9 inhibition?
Ulf Landmesser, M John Chapman, Jane K Stock, et al.
International Journal of Behavioral Medicine
|
October 25, 2012
European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)
Joep Perk, Guy De Backer, Helmut Gohlke, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 30, 2022
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary
Adam Timmis, Panos Vardas, Nick Townsend, et al.
European Heart Journal
|
October 19, 2017
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
Ulf Landmesser, M John Chapman, Jane K Stock, et al.
Atherosclerosis
|
June 16, 2012
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
Joep Perk, Guy De Backer, Helmut Gohlke, et al.
Nature Plants
|
December 17, 2020
Author Correction: Selection of a subspecies-specific diterpene gene cluster implicated in rice disease resistance
Chuansong Zhan, Long Lei, Zixin Liu, et al.
Nature Plants
|
December 10, 2020
Selection of a subspecies-specific diterpene gene cluster implicated in rice disease resistance
Chuansong Zhan, Long Lei, Zixin Liu, et al.
European Heart Journal
|
August 30, 2007
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 2, 2017
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
Ian Graham, Chuck Shear, Pieter De Graeff, et al.
European Heart Journal
|
February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
Steven H J Hageman, Ailsa J McKay, Peter Ueda, et al.
Page
of 17